Wnt/β-catenin signaling pathway and lipolysis enzymes participate in methylprednisolone induced fat differential distribution between subcutaneous and visceral adipose tissue

- Methylprednisolone impairs glucose tolerance and lipid profile of rats.
- Methylprednisolone changes the characteristics of adipose tissue.
- Methylprednisolone inhibits Wnt/β-catenin signaling pathway in SAT and VAT.
- Methylprednisolone increases expression of ATGL and HSL in SAT.
- Methylprednisolone decreases expression of ATGL and HSL in VAT.